Creative Medical Technology Holdings, Inc. (CELZ) financial statements (2021 and earlier)

Company profile

Business Address 211 E. OSBORN RD.
PHOENIX, AZ 85012
State of Incorp. NV
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Receivables 000   
Total current assets:0000000
Noncurrent Assets
Intangible assets, net (including goodwill)10000  
Intangible assets, net (excluding goodwill)10000  
Total noncurrent assets:10000  
TOTAL ASSETS:1100000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1000000
Accounts payable0000000
Accrued liabilities00000  
Debt1110   
Derivative instruments and hedges, liabilities39731   
Due to related parties0000000
Other undisclosed current liabilities00000  
Total current liabilities:41942000
Noncurrent Liabilities
Long-term debt and lease obligation   0   
Long-term debt, excluding current maturities   0   
Liabilities, other than long-term debt   000 
Accounts payable and accrued liabilities   00  
Due to related parties    00 
Total noncurrent liabilities:   000 
Total liabilities:41942000
Stockholders' equity
Stockholders' equity attributable to parent, including:(40)(8)(4)(2)(0)(0)(0)
Common stock1010000
Additional paid in capital2117121100
Accumulated deficit(62)(26)(17)(3)(1)(0)(0)
Other undisclosed stockholders' equity attributable to parent000    
Total stockholders' equity:(40)(8)(4)(2)(0)(0)(0)
TOTAL LIABILITIES AND EQUITY:1100000

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues0000   
Cost of revenue(0)(0)(0)(0)   
Gross profit:000(0)   
Operating expenses(1)(1)(1)(1)(1)(0)(0)
Other operating expense, net      (0)
Other undisclosed operating income (loss)    (0) 0
Operating loss:(1)(1)(1)(1)(1)(0)(0)
Nonoperating expense(35)(7)(13)(1)   
Interest and debt expense(1)(0)0(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(38)(9)(13)(3)(1)(0)(0)
Other undisclosed income (loss) from continuing operations before income taxes10(0)    
Net loss:(36)(8)(14)(3)(1)(0)(0)
Other undisclosed net income attributable to parent   00  
Net loss available to common stockholders, diluted:(36)(8)(14)(3)(1)(0)(0)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(36)(8)(14)(3)(1)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(36)(8)(14)(3)(1)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: